Literature DB >> 24853404

Going beyond the numbers - a call to redefine polypharmacy.

Carmel M Hughes1, Janine A Cooper, Cristin Ryan.   

Abstract

Mesh：

Year:  2014        PMID： 24853404      PMCID： PMC4093916          DOI： 10.1111/bcp.12284

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  9 in total

1.  In defence of polypharmacy.

Authors:  J K Aronson
Journal:  Br J Clin Pharmacol       Date:  2004-02       Impact factor: 4.335

Review 2.  Polypharmacy: a new paradigm for quality drug therapy in the elderly?

Authors:  Jerry H Gurwitz
Journal:  Arch Intern Med       Date:  2004-10-11

Review 3.  Interventions to improve the appropriate use of polypharmacy for older people.

Authors:  Susan M Patterson; Carmel Hughes; Ngaire Kerse; Chris R Cardwell; Marie C Bradley
Journal:  Cochrane Database Syst Rev       Date:  2012-05-16

Review 4.  Overcoming problems with polypharmacy and drug misuse in the elderly.

Authors:  S C Montamat; B Cusack
Journal:  Clin Geriatr Med       Date:  1992-02       Impact factor: 3.076

5.  Polypharmacy: one of the greatest prescribing challenges in general practice.

Authors:  Rupert A Payne; Anthony J Avery
Journal:  Br J Gen Pract       Date:  2011-02       Impact factor: 5.386

6.  Is polypharmacy always hazardous? A retrospective cohort analysis using linked electronic health records from primary and secondary care.

Authors:  Rupert A Payne; Gary A Abel; Anthony J Avery; Stewart W Mercer; Martin O Roland
Journal:  Br J Clin Pharmacol       Date:  2014-06       Impact factor: 4.335

7.  Use of medications and polypharmacy are increasing among the elderly.

Authors:  Tarja Linjakumpu; Sirpa Hartikainen; Timo Klaukka; Juha Veijola; Sirkka-Liisa Kivelä; Raimo Isoaho
Journal:  J Clin Epidemiol       Date:  2002-08       Impact factor: 6.437

Review 8.  Reduction of polypharmacy in the elderly: a systematic review of the role of the pharmacist.

Authors:  Victoria Rollason; Nicole Vogt
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

9.  Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study.

Authors:  Karen Barnett; Stewart W Mercer; Michael Norbury; Graham Watt; Sally Wyke; Bruce Guthrie
Journal:  Lancet       Date:  2012-05-10       Impact factor: 79.321
  9 in total
  14 in total

1.  Determinants of change in polypharmacy status in Switzerland: the population-based CoLaus study.

Authors:  Nazanin Abolhassani; Julien Castioni; Pedro Marques-Vidal; Peter Vollenweider; Gérard Waeber
Journal:  Eur J Clin Pharmacol       Date:  2017-06-21       Impact factor: 2.953

Review 2.  Impact of strategies to reduce polypharmacy on clinically relevant endpoints: a systematic review and meta-analysis.

Authors:  Tim Johansson; Muna E Abuzahra; Sophie Keller; Eva Mann; Barbara Faller; Christina Sommerauer; Jennifer Höck; Christin Löffler; Anna Köchling; Jochen Schuler; Maria Flamm; Andreas Sönnichsen
Journal:  Br J Clin Pharmacol       Date:  2016-05-07       Impact factor: 4.335

3.  Reducing potentially inappropriate drug prescribing in nursing home residents: effectiveness of a geriatric intervention.

Authors:  Charlène Cool; Philippe Cestac; Cécile McCambridge; Laure Rouch; Philipe de Souto Barreto; Yves Rolland; Maryse Lapeyre-Mestre
Journal:  Br J Clin Pharmacol       Date:  2018-05-14       Impact factor: 4.335

4.  Medication Appropriateness in Vulnerable Older Adults: Healthy Skepticism of Appropriate Polypharmacy.

Authors:  Terri R Fried; Marcia C Mecca
Journal:  J Am Geriatr Soc       Date:  2019-01-30       Impact factor: 5.562

5.  Quality of prescribing in community-dwelling elderly patients in France: an observational study in community pharmacies.

Authors:  E Bourcier; F Mille; V Brunie; V Korb-Savoldelli; C Lafortune; M Buyse; C Fernandez; P Hindlet
Journal:  Int J Clin Pharm       Date:  2017-09-14

6.  Clinically important drug-drug interactions in poly-treated elderly outpatients: a campaign to improve appropriateness in general practice.

Authors:  Emanuel Raschi; Carlo Piccinni; Vincenzo Signoretta; Lucio Lionello; Silvia Bonezzi; Marcello Delfino; Lucia Di Candia; Lucio Di Castri; Fabio Pieraccini; Daniela Carati; Elisabetta Poluzzi; Fabrizio De Ponti
Journal:  Br J Clin Pharmacol       Date:  2015-11-12       Impact factor: 4.335

Review 7.  Appropriate Polypharmacy and Medicine Safety: When Many is not Too Many.

Authors:  Cathal A Cadogan; Cristín Ryan; Carmel M Hughes
Journal:  Drug Saf       Date:  2016-02       Impact factor: 5.606

8.  Trends and interaction of polypharmacy and potentially inappropriate prescribing in primary care over 15 years in Ireland: a repeated cross-sectional study.

Authors:  Frank Moriarty; Colin Hardy; Kathleen Bennett; Susan M Smith; Tom Fahey
Journal:  BMJ Open       Date:  2015-09-18       Impact factor: 2.692

9.  Potentially inappropriate prescribing in two populations with differing socio-economic profiles: a cross-sectional database study using the PROMPT criteria.

Authors:  Janine A Cooper; Frank Moriarty; Cristín Ryan; Susan M Smith; Kathleen Bennett; Tom Fahey; Emma Wallace; Caitriona Cahir; David Williams; Mary Teeling; Carmel M Hughes
Journal:  Eur J Clin Pharmacol       Date:  2016-01-28       Impact factor: 2.953

10.  Improving appropriate polypharmacy for older people in primary care: selecting components of an evidence-based intervention to target prescribing and dispensing.

Authors:  Cathal A Cadogan; Cristín Ryan; Jill J Francis; Gerard J Gormley; Peter Passmore; Ngaire Kerse; Carmel M Hughes
Journal:  Implement Sci       Date:  2015-11-16       Impact factor: 7.327
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.